Press Releases from SonaCare Medical

Press Releases

UCL's Mark Emberton, MD, to Direct Premier Training Center for the Use of Advanced Imaging Capabilities to Localize Cancer and Deliver HIFU Treatment Using Tissue Preserving Techniques

CHARLOTTE, N.C., Thursday, May 2, 2013 - SonaCare Medical, a global leader in minimally invasive HIFU technologies, announced today that it has partnered with University College London (UCL) to create a HIFU Center of Excellence. The Center of Excellence will provide physician training and proctoring along with clinical studies, patient satisfaction research and advanced technology development associated with two innovative HIFU systems: the Sonatherm® laparoscopic HIFU surgical ablation system and the Sonablate® 500 transrectal HIFU surgical ablation system.

Press Releases

SmartTarget Offers a Clinically Tested and Practical Solution for MRI-Ultrasound Fusion Designed to Enable Targeted Prostate Focal HIFU Treatment

CHARLOTTE, N.C. and LONDON, UK, Tuesday, April 30, 2013 -- SonaCare Medical, a global leader in minimally invasive High-Intensity Focused Ultrasound (HIFU) technologies, and UCL Business PLC (UCLB), a leading technology transfer company that supports and commercializes research and innovations from UCL (University College London), today announced a partnership to integrate SmartTarget image registration and fusion software into SonaCare Medical's innovative HIFU systems.

Press Releases

Global Launch Generates Strong Support for SonaCare Medical's Urology Platform Technology to Provide HIFU Surgical Ablation Systems for a Wide Range of Urological Indications

CHARLOTTE, N.C., April 4, 2013 - SonaCare Medical, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, successfully launched two new products at the recent European Association of Urology (EAU) Congress in Milan, Italy.

Press Releases

New Products Build on Growing Adoption of SonaCare Medical HIFU Technologies Following a Record 130% Increase in International Sales and a 3X Expansion in International Distributors

CHARLOTTE, N.C., March 14, 2013 - SonaCare Medical, LLC (SonaCare Medical), a leader in minimally invasive high intensity focused ultrasound (HIFU) technologies, will showcase two new HIFU products at the 28th annual European Association of Urology (EAU) Congress, in Milan, Italy, March 15-19, 2013.  (Booth: G02)

Press Releases

Company Renamed to Align with Strategic Technology Vision of Urology Devices Utilizing HIFU to Treat a Range of Urological Indications

CHARLOTTE, N.C. – February 20, 2013 – USHIFU, LLC (US HIFU), a global leader in minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today that it has changed the company's name to SonaCare Medical, LLC (SonaCare Medical). Effective immediately, US HIFU will function as SonaCare Medical and all subsidiaries and operating units, including International HIFU and Focus Surgery, will be rebranded to reflect their relationship to SonaCare Medical.

Press Releases

Growing Interest in Potential of HIFU to Offer an Alternative Treatment for Prostate Cancer Designed to Balance Effectiveness and Quality of Life

Charlotte, N.C. – November 19, 2012 -- The ability for technology from USHIFU, LLC (US HIFU), a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies, to offer another treatment option for prostate cancer designed to balance treatment effectiveness and quality of life was the focus of several research studies presented recently at the Third International Symposium on Focused Ultrasound.  

Press Releases

Focal Therapy Using Sound Waves to Target Individual Areas of Cancer Shows Promise as Alternative to Traditional Treatments for Prostate Cancer

Charlotte, N.C. – April 17, 2012 -- A new treatment for prostate cancer using high intensity focused ultrasound (HIFU) to deliver focal treatment may provide an alternative to traditional treatment with significantly fewer side effects, according to results from a study published in the current issue of Lancet Oncology (DOI:10.1016/S1470-2045(12)70121-3). Incontinence and erectile dysfunction are common side effects of treatments for localized prostate cancer.

Page 6 of 6

Latest News

17 November 2020

Read More...
31 July 2020

Read More...

Connect With Us

Copyright © 2021 Sonacare Medical

Design & Development By Medtech Momentum

Search

(888) 874-438410130 Perimeter Pkwy, Suite 250 Charlotte, NC 28216